<div>
  <p>
  </p>
  <ul>
    <li>
      <p>
        AI-powered drug discovery platform developer Variational AI has partnered with biopharmaceutical company Rakovina Therapeutics to develop novel cancer therapies using AI-based drug discovery technology.
      </p>
    </li>
    <li>
      <p>
        This collaboration entails Variational AI identifying potential compounds for cancer treatment using its Enki AI platform, while Rakovina Therapeutics will synthesize and evaluate these potential drugs. The partnership aims to expand Rakovina's pipeline in developing kinase-targeted therapies alongside its existing PARP inhibitors. The potential drug candidates are expected to be delivered within four to six weeks and evaluated within 12 to 18 months. 
      </p>
    </li>
  </ul>
  <p>
  </p>
</div>


<div>
  <p>
    <a href="https://www.globenewswire.com/news-release/2024/09/17/2947313/0/en/Rakovina-Therapeutics-and-Variational-AI-Announce-Drug-Discovery-Collaboration.html">
      Press release
    </a>
  </p>
</div>


AI Drug Discovery

PROMINENT_CATEGORY

<div>

 <p>AI-powered drug discovery platform developer Variational AI has teamed up with biopharmaceutical company Rakovina Therapeutics to create new cancer treatments using AI-based drug discovery technology.</p>
 <p>As part of the partnership, Variational AI will use its Enki AI platform to identify potential compounds for cancer treatment. Rakovina Therapeutics, on the other hand, will be responsible for synthesizing and evaluating the potential drugs. The goal is to expand Rakovina's product portfolio in developing kinase-targeted therapies, along with its existing PARP inhibitors. The potential drug candidates are anticipated to be delivered within four to six weeks and evaluated within 12 to 18 months.</p>

</div>

Variational AI and Rakovina Therapeutics partner to develop cancer therapies using AI technology

Data Infrastructure & Analytics

<div>
 
 <p>Graph query engine company PuppyGraph has secured a seed funding of USD 5 million led by defy.vc. It has also entered into strategic alliances with Google Cloud and Databricks to become Unity Catalog's premier graph analytics partner.</p>
 <p>The recently acquired capital will be utilized to propel product development, expand the team, and augment market presence, with the intention to make the graph query engine accessible to more organizations globally.</p>
 <p>Established in 2024, PuppyGraph provides software solutions for relational data analysis in graph format. The core product allows organizations to graphically query their existing data without the need for data migration or Extraction, Transformation, Loading (ETL) processes. This system is capable of processing intricate graph queries over large datasets and seamlessly integrates with pre-existing data warehouses and lakes. The company provides two product variations: a gratis Developer Edition for single-node deployments and an Enterprise Edition extending advanced features for production realms.</p>
 
</div>

PuppyGraph raises USD 5 million in seed funding to expand product development

AI, robotics, and IoT to streamline the flow of goods and information

Logistics Tech

INCUMBENTS_PRESENT

<div>
 <p>Global freight and logistics provider, FedEx, has launched a new automated facility at its Memphis World Hub as part of a USD 1.5 billion investment. This facility, which is LEED-certified, forms part of the company's efforts to modernize the Memphis World Hub.</p>
 <p>Spanning 1.3 million square feet and four levels, the facility boasts 11 miles of conveyor belt, advanced six-sided scanning technology, a specific area for bulky shipments, and a new Hub Operations Command Center. It can process up to 56,000 packages per hour thanks to advanced data-driven technology for efficient sorting and handling of packages.</p>
 <p>FedEx states that the new facility can manage over half of the volume from the main sorting process. This capacity significantly enhances sorting times and enables quicker delivery to final destinations.</p>
 
</div>

FedEx opens automated facility at Memphis World Hub

Additive manufacturing makes objects by systematically adding material via a CAD program

Additive Manufacturing

ANALYST_QUICK_TAKE

<div>
 <p>3D printer manufacturer, Formlabs, has launched the Creator Series of resins, catered for amateur-grade LCD and DLP 3D printers. Made in the US, the new series is available on Amazon for USD 45 per kilogram.</p>
 <p>The series introduces two products: Creator Tough Resin, with ABS-like properties and a paintable matte gray finish, and Creator Super Clear Resin, that's transparent and can be polished, dyed, or coated. The resins are compatible with prevalent hobbyist printers such as Elegoo Mars, Anycubic Photon, and Creality Halot Mage.</p>
 <p>Formlabs underlines that these resins mitigate safety concerns in the hobbyist sector by producing fewer volatile organic compounds (VOCs), removing harmful odors, and preserving professional-grade quality, yet being cheaper than regular options.</p>
</div> <p><b>Analyst QuickTake:<br>
</b> The ongoing Formnext expo has seen the launch of a number of new AM materials over the last month. These include 1) <a href="https:<br>
//sp-edge.com/companies/3518197"> Xenia Materials </a> , which <a href="https:<br>
//sp-edge.com/updates/35759"> launched four new high-performance filaments </a> for Fused Deposition Modeling (FDM), 2) <a href="https:<br>
//sp-edge.com/companies/13868"> Henkel </a> , which <a href="https:<br>
//sp-edge.com/updates/32401"> unveiled Loctite 3D IND6845 </a> , a thermoplastic polyurethane designed for industrial applications, and 3) <a href="https:<br>
//sp-edge.com/companies/251004"> Nano Dimension </a> , which <a href="https:<br>
//sp-edge.com/updates/35101"> launched a new DLP 3D printing resin </a> called Ataru.</p>

Formlabs launches Creator Series resins for 3D printers at Formnext 2024

<div>
 <p>3D Systems, a company that offers additive manufacturing solutions, has unveiled the PSLA 270 printer and the Wash 400/400F and Cure 400 post-processing solutions. These new products are scheduled for release in the first quarter of 2025.</p>
 <p>Designed with project-based SLA 3D printing technology, the PSLA 270 caters to the printing of medium-sized parts. On the other hand, the Wash 400/400F and Cure 400 facilitate the cleaning and curing of resin-printed components. The Wash system incorporates a dual design suited for both dirty and clean washing procedures. The Cure 400 is equipped with a rotary table, comprehensive spectrum LEDs, and boasts a curing volume measuring 400 x 400 x 400 mm.</p>
 <p>Reportedly, these advanced systems are compatible with all 3D Systems SLA, Figure 4, and PSLA systems, maximizing floor space and enhancing user workflows for medium-frame printer systems.</p>
</div>

3D Systems launches PSLA 270 printer and post-processing solutions

<div>
 <p>Caracol, a provider of large format additive manufacturing solutions, has introduced Vipra AM, a robotic metal 3D printing platform designed for the production of large-scale metal parts. The platform, showcasing two configurations, Vipra XQ and Vipra XP, is set to be showcased at Formnext 2024 in Frankfurt.</p>
 <p>Vipra AM employs Direct Energy Deposition technology along with wire arc additive manufacturing processes integrated into a turnkey system that includes hardware, software, and automation. The Vipra XQ focuses on delivering high-quality components using Plasma Arc Deposition, ensuring exceptional strength and precision. In contrast, the Vipra XP emphasizes productivity and cost-effectiveness, particularly suited for complex large-scale metal projects.</p>
 <p>Caracol asserts that the Vipra AM system aids manufacturers in reducing material waste, quickening lead times, and enhancing production lines without necessitating major alterations to existing operations. The platform can produce a variety of applications like load-bearing parts, lightweight structures, high-temperature molds, cladding, repair components, and on-demand spare parts.</p>
</div>

Caracol launches Vipra AM metal 3D printing platform

Technology providers that enhance satellite operations

Next-gen Satellites

<div>
 <p>Earth observation satellite operator, ICEYE and government IT solutions provider, Carahsoft Technology Corp, have teamed up to deliver insights into natural disasters to US government agencies. Carahsoft will serve as ICEYE’s Master Government Aggregator, allowing government agencies access to ICEYE’s disaster data via several contract vehicles like NASA SEWP V, ITES-SW2, NASPO ValuePoint, and OMNIA Partners. ICEYE's satellite constellation will provide near real-time data for flood and wildfire monitoring, enabling agencies to improve their disaster response, recovery, and mitigation efforts, irrespective of environmental circumstances.</p> 
</div>

ICEYE partners with Carahsoft to provide SAR satellite data to US government agencies

<div>
 <p>Geospatial intelligence provider, BlackSky Technology, has purchased the remaining 50% stake in LeoStella, a firm that designs and manufactures small satellites. The acquisition, for which the financial details were not disclosed, came from BlackSky's joint venture partner, Thales Alenia Space.</p>
 <p>LeoStella, which builds satellites for BlackSky, was previously a 50:50 joint venture between BlackSky and Thales Alenia Space. The aim of the acquisition is to optimize the supply chain and production operations for BlackSky's upcoming Gen-3 satellite project. The Gen-3 satellites will provide higher frequency monitoring and 35 cm resolution, with the first one anticipated to be shipped to the Rocket Lab's launch site in New Zealand in the near future.</p>
</div>

BlackSky acquires remaining 50% stake in LeoStella

Leveraging personal data for custom-fit diagnosis and treatment

Precision Medicine

<div>
 
 <p>GenomOncology and Genomenon have formed a strategic partnership to streamline germline variant classification and genomic reporting. GenomOncology will integrate Genomenon's curated genomic data—referred to as "mastermind data"—into its platform. This will improve the efficiency and accuracy of genomic reporting. The extensive dataset will strengthen healthcare providers' capabilities of providing accurate genomic insights, which will assist in the diagnosis and treatment of hereditary conditions, cancer, and rare diseases.&nbsp;</p>
 
</div> <p><b>Analyst QuickTake:<br>
 </b> Earlier, in September 2024, GenomOncology <a href="https:<br>
//sp-edge.com/updates/33461"> partnered </a> with Precipio to advance testing and clinical genomic reporting for myeloid neoplasms.The partnership aimed to enhance variant interpretation and accelerate the diagnostic process, delivering fast results to healthcare providers with potential treatment recommendations to enhance patient care.</p>

GenomOncology partners with Genomenon to streamline germline variant classification and reporting

<div>
 
 <p>UK-based AI precision medicine company Concr has announced a partnership with genetic and molecular data firm CariGenetics to improve and diversify data used in global healthcare. The partnership aims at increasing the use of genetic and molecular data from the Caribbean region for training AI models and creating more inclusive and effective treatments for diverse populations. The collaboration will also aid in the development of precision medicine and enhance its accessibility to the Caribbean communities.</p>
 <p>Concr uses AI and Bayesian computational frameworks adopted from astrophysics to analyze and integrate disparate oncology data. This helps in enabling precision medicine and improving drug development. Concr's technology, such as its FarrSight-Twin platform, creates individualized digital twins by merging genomic data, whole-slide imaging, and clinical information. This combined data is then used to predict treatment responses to chemotherapy and immunotherapy.
</p>
 
</div>

Concr partners with CariGenetics to improve precision medicine with AI and diverse data

<div>
<p>Concr, a precision medicine company based in the UK that utilises AI, has formed an alliance with CariGenetics, a firm specializing in molecular and genetic data. Their joint objective is to diversify and enhance the data used in global healthcare. The partnership aims to boost the usage of the Caribbean region's genetic and molecular data, to train AI models. This step aims to produce more all-inclusive and effective treatments for varied population groups. The collaboration also hopes to contribute to the progression of precision medicine and broaden its reach within Caribbean communities.</p>
<p>Concr uses AI and Bayesian computational frameworks, borrowed from astrophysics, to analyse and incorporate varying oncology data, with the ultimate aim being to assist precision medicine and speed up the development of drugs. The firm's technology, encompassing the FarrSight-Twin platform, forms individualized digital twins. The process works by merging genomic data, whole-slide imaging, and medical information to precall the patient response to chemotherapy and immunotherapy treatments.</p>
</div>

All Updates

Variational AI and Rakovina Therapeutics partner to develop cancer therapies using AI technology

PuppyGraph raises USD 5 million in seed funding to expand product development

FedEx opens automated facility at Memphis World Hub

Formlabs launches Creator Series resins for 3D printers at Formnext 2024

3D Systems launches PSLA 270 printer and post-processing solutions

Caracol launches Vipra AM metal 3D printing platform

ICEYE partners with Carahsoft to provide SAR satellite data to US government agencies

BlackSky acquires remaining 50% stake in LeoStella

GenomOncology partners with Genomenon to streamline germline variant classification and reporting

Concr partners with CariGenetics to improve precision medicine with AI and diverse data

Concr partners with CariGenetics to improve precision medicine with AI and diverse data

AI Drug Discovery

Variational AI and Rakovina Therapeutics partner to develop cancer therapies using AI technology

Contact us